Use access key #2 to skip to page content.
$9.51 -0.26 (-2.66%)
10/10/2008 4:00 PM

Momenta Pharmaceuticals, Inc. (MNTA)

CAPS Rating:
*****

A biotechnology company specializing in the detailed structural analysis of complex mixture drugs of the development of generic or biosimilar versions of complex drug products as well as to the discovery and development of novel drugs.

View All Commentary (MNTA)

Recs

0

Avatar nesselsdorf1187 (99.44) Submitted: 5/22/08 12:14 PM : Outperform Start Price: $13.27 MNTA Score: 25.50

Risky play that company can succeed in their efforts. Could be very rewarding but I can get trashed with this pick very badly too.

Report this Post Replies: 0 | Reply

Featured Broker Partners